U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    IL5RA interleukin 5 receptor subunit alpha [ Homo sapiens (human) ]

    Gene ID: 3568, updated on 3-Apr-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Epithelial IL5RA promotes epithelial-mesenchymal transition in pulmonary fibrosis via Jak2/STAT3 cascade.

    Epithelial IL5RA promotes epithelial-mesenchymal transition in pulmonary fibrosis via Jak2/STAT3 cascade.
    Chen S, Zhao T, Xie S, Wan X.

    03/14/2024
    The Study of the Influence of IL5RA Variants on Chronic Obstructive Pulmonary Disease.

    The Study of the Influence of IL5RA Variants on Chronic Obstructive Pulmonary Disease.
    Li S, Lin L, Zhao J, Yang Z, Zhong Y, Huang L, Chen J, Zhang L, Ding Y, Xie T.

    11/3/2023
    IL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of multiple myeloma.

    IL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of multiple myeloma.
    Xu C, Gao M, Zhang J, Fu Y., Free PMC Article

    05/30/2023
    Transcriptional Regulation of the Human IL5RA Gene through Alternative Promoter Usage during Eosinophil Development.

    Transcriptional Regulation of the Human IL5RA Gene through Alternative Promoter Usage during Eosinophil Development.
    Laffey KG, Du J, Schrum AG, Ackerman SJ., Free PMC Article

    10/30/2021
    MiRNA-495-3p Attenuates TNF-alpha Induced Apoptosis and Inflammation in Human Nucleus Pulposus Cells by Targeting IL5RA.

    MiRNA-495-3p Attenuates TNF-α Induced Apoptosis and Inflammation in Human Nucleus Pulposus Cells by Targeting IL5RA.
    Lin X, Lin Q.

    07/17/2021
    Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy.

    Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy.
    Bakakos A, Rovina N, Bakakos P., Free PMC Article

    05/15/2021
    Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab.

    Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab.
    Landi C, Cameli P, Vantaggiato L, Bergantini L, d'Alessandro M, Perruzza M, Carleo A, Shaba E, Di Giuseppe F, Angelucci S, Bargagli E, Bini L.

    04/17/2021
    IL-5Ralpha marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease.

    IL-5Rα marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease.
    Buchheit KM, Dwyer DF, Ordovas-Montanes J, Katz HR, Lewis E, Vukovic M, Lai J, Bankova LG, Bhattacharyya N, Shalek AK, Barrett NA, Boyce JA, Laidlaw TM., Free PMC Article

    02/20/2021
    Expression of IL-5 receptor alpha by murine and human lung neutrophils.

    Expression of IL-5 receptor alpha by murine and human lung neutrophils.
    Gorski SA, Lawrence MG, Hinkelman A, Spano MM, Steinke JW, Borish L, Teague WG, Braciale TJ., Free PMC Article

    03/7/2020
    Increased activation of B-cells is present following successful Tuberculosis treatment, and the expression of FASLG and IL5RA could potentially be utilized as a signature to monitor treatment response.

    Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA.
    van Rensburg IC, Wagman C, Stanley K, Beltran C, Ronacher K, Walzl G, Loxton AG., Free PMC Article

    02/24/2018
    Interleukin-5Ralpha-targeted treatments offer promises to patients with eosinophilic respiratory disorders; review

    Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs.
    Varricchi G, Bagnasco D, Borriello F, Heffler E, Canonica GW., Free PMC Article

    12/17/2016
    This is the first study to show significant associations between IL5RA SNP rs17881144, the ATTAGA haplotype, the GTAGCA haplotype, and the GCTGCA haplotype and eczema.

    IL5RA polymorphisms, smoking and eczema in Japanese women: the Kyushu Okinawa Maternal and Child Health Study.
    Miyake Y, Tanaka K, Arakawa M.

    09/12/2015
    This is the first study to show significant associations between IL5RA SNP rs6771148, the ACTAGA haplotype, and the GTAGCA haplotype and the risk of rhinoconjunctivitis.

    Case-control study of rhinoconjunctivitis associated with IL5RA polymorphisms in Japanese women: the Kyushu Okinawa Maternal and Child Health Study.
    Miyake Y, Tanaka K, Arakawa M.

    09/13/2014
    The MDR analysis showed a potential interaction of C1GALT1-330G/T (rs1008898) and IL5RA31+197A/G (rs340833) on the susceptibility of IgAN (P<0.001). Gene-gene interaction may have some influence on the susceptibility to IgA nephropathy.

    Interaction of C1GALT1-IL5RA on the susceptibility to IgA nephropathy in Southern Han Chinese.
    Wang W, Sun Y, Fu Y, Yu X, Li M.

    11/16/2013
    These findings suggest that a functional polymorphism in IL5RA may contribute to eosinophil and mast cell activation along with specific IgE responses to staphylococcal enterotoxin A in aspirin-exacerbated respiratory disease patients.

    A genetic effect of IL-5 receptor α polymorphism in patients with aspirin-exacerbated respiratory disease.
    Losol P, Kim SH, Shin YS, Ye YM, Park HS., Free PMC Article

    10/26/2013
    The study reports the crystal structure of dimeric IL-5 in complex with the IL5RA extracellular domains.

    Structural basis of interleukin-5 dimer recognition by its α receptor.
    Kusano S, Kukimoto-Niino M, Hino N, Ohsawa N, Ikutani M, Takaki S, Sakamoto K, Hara-Yokoyama M, Shirouzu M, Takatsu K, Yokoyama S., Free PMC Article

    09/15/2012
    REVIEW: Interleukin-5 and IL-5 receptor in health and disease

    Interleukin-5 and IL-5 receptor in health and diseases.
    Takatsu K., Free PMC Article

    05/5/2012
    we determined the structure of IL-5 bound to the extracellular domain of IL-5Ralpha.

    Structure analysis of the IL-5 ligand-receptor complex reveals a wrench-like architecture for IL-5Rα.
    Patino E, Kotzsch A, Saremba S, Nickel J, Schmitz W, Sebald W, Mueller TD.

    04/14/2012
    IL-5Ralpha expression on eosinophils inversely correlated with eosinophilia and was significantly elevated in patients with systemic mastocytosis without eosinophilia

    IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis.
    Wilson TM, Maric I, Shukla J, Brown M, Santos C, Simakova O, Khoury P, Fay MP, Kozhich A, Kolbeck R, Metcalfe DD, Klion AD., Free PMC Article

    12/17/2011
    Study of engineered deglycosylated IL-5 receptor alpha variant proves that unique carbohydrate groups in multiglycosylated receptors can be utilized asymmetrically for function.

    A protein engineering approach differentiates the functional importance of carbohydrate moieties of interleukin-5 receptor α.
    Ishino T, Economou NJ, McFadden K, Zaks-Zilberman M, Jost M, Baxter S, Contarino MR, Harrington AE, Loll PJ, Pasut G, Lievens S, Tavernier J, Chaiken I.

    10/22/2011
    Polymorphisms in IL5RA, LPL, ITGA2 and NOS3 genes were independently associated with ischemic stroke in Chinese diabetic population.

    Predictive role of polymorphisms in interleukin-5 receptor alpha-subunit, lipoprotein lipase, integrin A2 and nitric oxide synthase genes on ischemic stroke in type 2 diabetes--an 8-year prospective cohort analysis of 1327 Chinese patients.
    Luk AO, Wang Y, Ma RC, Tam CH, Ng MC, Lam V, Yang X, Baum L, Tong PC, Chan JC, So WY.

    07/2/2011
    Increased serum level precedes the development of eczema in children

    Increased serum-soluble interleukin-5 receptor alpha level precedes the development of eczema in children.
    Semic-Jusufagic A, Gevaert P, Bachert C, Murray C, Simpson A, Custovic A.

    05/21/2011
    Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)

    Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
    Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators., Free PMC Article

    09/15/2010
    Syntenin forms complexes with multiple IL-5Ralpha chains

    Regulation of myelopoiesis through syntenin-mediated modulation of IL-5 receptor output.
    Beekman JM, Verhagen LP, Geijsen N, Coffer PJ.

    01/21/2010
    The expression of SOL-IL-5Ralpha and TM-IL-5Ralpha differs according to the eosinophil activation state and localization in the body (blood vs tissue) and may therefore be involved in the fine-tuning of the eosinophil homeostasis.

    Differential expression of the interleukin 5 receptor alpha isoforms in blood and tissue eosinophils of nasal polyp patients.
    Gevaert P, Hellman C, Lundblad L, Lundahl J, Holtappels G, van Cauwenberge P, Tavernier J, Bachert C.

    01/21/2010
    firstprevious page of 2 nextlast